» Articles » PMID: 24293462

Comorbidities of COPD

Abstract

By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality. Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco smoking is a common risk factor for many comorbidities, including coronary heart disease, heart failure and lung cancer. Comorbidities such as pulmonary artery disease and malnutrition are directly caused by COPD, whereas others, such as systemic venous thromboembolism, anxiety, depression, osteoporosis, obesity, metabolic syndrome, diabetes, sleep disturbance and anaemia, have no evident physiopathological relationship with COPD. The common ground between most of these extrapulmonary manifestations is chronic systemic inflammation. All of these diseases potentiate the morbidity of COPD, leading to increased hospitalisations and healthcare costs. They can frequently cause death, independently of respiratory failure. Comorbidities make the management of COPD difficult and need to be evaluated and treated adequately.

Citing Articles

SCGB1A1 as a Key Regulator of Splenic Immune Dysfunction in COPD: Insights From a Murine Model.

Chen X, Wang Q, Gong M, Wu Y, Huang X, Ye F Int J Chron Obstruct Pulmon Dis. 2025; 20:497-509.

PMID: 40060920 PMC: 11887496. DOI: 10.2147/COPD.S506332.


Experiences of Home-Based Pulmonary Rehabilitation With mHealth and Centre-Based Pulmonary Rehabilitation in People With Chronic Obstructive Pulmonary Disease: A Qualitative Study.

Rutherford H, Dale M, Wootton S, Pithavadian R, Dennis S, Brown S Health Expect. 2025; 28(2):e70181.

PMID: 40019189 PMC: 11869189. DOI: 10.1111/hex.70181.


Diagnosis and management of comorbid disease in COPD.

Cronin E, Cushen B Breathe (Sheff). 2025; 21(1):240099.

PMID: 40007528 PMC: 11851148. DOI: 10.1183/20734735.0099-2024.


Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.

Di Chiara C, Sartori G, Fantin A, Castaldo N, Crisafulli E Medicina (Kaunas). 2025; 61(1).

PMID: 39859079 PMC: 11766895. DOI: 10.3390/medicina61010097.


Association between lipid accumulation product and chronic obstructive pulmonary disease: a cross-sectional analysis.

Zhang S, Li Z, Zeng Y, Jiang J, Lei W, Chen S BMC Pulm Med. 2025; 25(1):6.

PMID: 39762812 PMC: 11702100. DOI: 10.1186/s12890-024-03465-0.


References
1.
Fisher M, Forfia P, Chamera E, Housten-Harris T, Champion H, Girgis R . Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009; 179(7):615-21. PMC: 2720125. DOI: 10.1164/rccm.200811-1691OC. View

2.
Lo Coco D, Mattaliano A, Lo Coco A, Randisi B . Increased frequency of restless legs syndrome in chronic obstructive pulmonary disease patients. Sleep Med. 2008; 10(5):572-6. DOI: 10.1016/j.sleep.2008.04.014. View

3.
Wagena E, van der Meer R, Ostelo R, Jacobs J, van Schayck C . The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respir Med. 2004; 98(9):805-15. DOI: 10.1016/j.rmed.2004.06.001. View

4.
Sin D, Paul Man S . Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003; 107(11):1514-9. DOI: 10.1161/01.cir.0000056767.69054.b3. View

5.
Krachman S, Chatila W, Martin U, Nugent T, Crocetti J, Gaughan J . Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest. 2005; 128(5):3221-8. DOI: 10.1378/chest.128.5.3221. View